Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Blastic Plasmacytoid Dendritic Cell Neoplasm and EBMT 2023

The BPDCN Channel on VJHemOnc is supported by Menarini and Stemline Therapeutics. The supporters have no influence over the production of the content.

View overview page
1:00
Unmet needs in BPDCN: CNS involvement & the importance of intrathecal chemotherapy prophylaxis
Marco Herling • 25 Apr 2023
1:41
Improvements in the awareness and diagnosis of BPDCN
Marco Herling • 25 Apr 2023
1:15
Managing patients with transplant-ineligible BDPCN with tagraxofusp
Marco Herling • 25 Apr 2023
1:23
The challenge of relapse in transplant-eligible & transplant-ineligible patients with BDPCN
Marco Herling • 25 Apr 2023
3:07
Frontline treatment in BPDCN & the best route to allogeneic transplantation
Marco Herling • 25 Apr 2023

The BPDCN Channel on VJHemOnc is supported by Menarini and Stemline Therapeutics.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The BPDCN Channel, please contact us

The content of VJHemOnc is intended for healthcare professionals